116 related articles for article (PubMed ID: 3080008)
21. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
Breton JC; Bouteille B; Sonan T
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
Onyeyili PA; Onwualu JE
Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO).
Jennings FW
Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020
[TBL] [Abstract][Full Text] [Related]
24. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
Mutomba MC; Li F; Gottesdiener KM; Wang CC
Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
[TBL] [Abstract][Full Text] [Related]
25. Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and DL-alpha-difluoromethylornithine; reversal by polyamines.
Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1982 Sep; 31(17):2833-6. PubMed ID: 6182888
[No Abstract] [Full Text] [Related]
26. Synergistic activity of 5-substituted 2-nitroimidazoles (Ro 15-0216 and benznidazole) and DL-alpha-difluoromethylornithine on Trypanosoma brucei brucei.
Zweygarth E; Kaminsky R; Sayer PD; van Nieuwenhove S
Ann Soc Belg Med Trop; 1990 Dec; 70(4):269-79. PubMed ID: 2291692
[TBL] [Abstract][Full Text] [Related]
27. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.
Byers TL; Bush TL; McCann PP; Bitonti AJ
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):527-33. PubMed ID: 1672500
[TBL] [Abstract][Full Text] [Related]
28. Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases.
Berger BJ; Fairlamb AH
Parasitology; 1992; 105 Suppl():S71-8. PubMed ID: 1308932
[TBL] [Abstract][Full Text] [Related]
29. The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness.
Na-Bangchang K; Doua F; Konsil J; Hanpitakpong W; Kamanikom B; Kuzoe F
Eur J Clin Pharmacol; 2004 Jun; 60(4):269-78. PubMed ID: 15141331
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
De Groof D; Bruneel H; Musumari TS; Ruppol JF
Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
[TBL] [Abstract][Full Text] [Related]
31. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
33. Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.
Ehrke MJ; Porter CW; Eppolito C; Mihich E
Cancer Res; 1986 Jun; 46(6):2798-803. PubMed ID: 3084078
[TBL] [Abstract][Full Text] [Related]
34. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.
Milord F; Loko L; Ethier L; Mpia B; Pépin J
Trans R Soc Trop Med Hyg; 1993; 87(4):473-7. PubMed ID: 8249087
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
[TBL] [Abstract][Full Text] [Related]
36. Effect of putrescine on the respiration of Trypanosoma brucei brucei.
Giffin BF; McCann PP; Bacchi CJ
Mol Biochem Parasitol; 1986 Aug; 20(2):165-71. PubMed ID: 3092047
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.
Sjoerdsma A; Golden JA; Schechter PJ; Barlow JL; Santi DV
Trans Assoc Am Physicians; 1984; 97():70-9. PubMed ID: 6442954
[No Abstract] [Full Text] [Related]
38. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)].
Hamon JF; Camara P
Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798
[TBL] [Abstract][Full Text] [Related]
39. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire.
Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K
Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
